FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2791688663> ?p ?o ?g. }

• W2791688663 endingPage "170" @default.
• W2791688663 startingPage "165" @default.
• W2791688663 abstract "Cervical intraepithelial neoplasia grade 2 (CIN2) frequently regresses, is typically slow-growing, and rarely progresses to cancer. Some women forgo immediate treatment, opting for conservative management (heightened surveillance with cytology and colposcopy), to minimize overtreatment and increased risk of obstetric complications; however, there are limited data examining clinical outcomes in these women. We performed a retrospective cohort analysis of younger women diagnosed with initially untreated CIN1/2, CIN2 and CIN2/3 lesions at Kaiser Permanente Northern California between 2003 and 2015. Clinical outcomes were categorized into five mutually exclusive hierarchical groups: cancer, treated, returned to routine screening, persistent high-grade lesion, or persistent low-grade lesion. Median follow-up for the 2,417 women was 48 months. Six women were diagnosed with cancer (0.2%), all with history of high-grade cytology, and none after a negative cotest. Thirty percent of women were treated, and only 20% returned to routine screening; 50% remained in continued intensive follow-up, of which 86% had either low-grade cytology/histology or high-risk human papillomavirus (HPV) positivity, but not necessarily persistence of a single HPV type. No cancers were detected after a single negative cotest in follow-up. Almost half of initially untreated women did not undergo treatment, but remained by protocol in colposcopy clinic for 2 or more years in the absence of persisting CIN2+ Their incomplete return to total negativity was possibly due to sequential new and unrelated low-grade abnormalities. The prolonged colposcopic surveillance currently required to return to routine screening in the absence of persisting CIN2+ might not be necessary after a negative cotest.Significance: Many younger women under conservative management following an initial CIN2 result remain in a clinical protocol of prolonged intensified surveillance without a subsequent diagnosis of CIN2 or more severe diagnoses. More research is needed to determine whether such prolonged management might be unnecessary following a negative cotest for those women with an initial CIN2 but otherwise only low-grade findings. Cancer Prev Res; 11(3); 165-70. ©2018 AACR." @default.
• W2791688663 created "2018-03-29" @default.
• W2791688663 creator A5004506157 @default.
• W2791688663 creator A5009110617 @default.
• W2791688663 creator A5019534637 @default.
• W2791688663 creator A5031936639 @default.
• W2791688663 creator A5033444828 @default.
• W2791688663 creator A5048359390 @default.
• W2791688663 creator A5054090794 @default.
• W2791688663 creator A5054472987 @default.
• W2791688663 creator A5060618328 @default.
• W2791688663 creator A5075288631 @default.
• W2791688663 creator A5091770473 @default.
• W2791688663 date "2018-03-01" @default.
• W2791688663 modified "2023-10-16" @default.
• W2791688663 title "Clinical Outcomes after Conservative Management of Cervical Intraepithelial Neoplasia Grade 2 (CIN2) in Women Ages 21–39 Years" @default.
• W2791688663 cites W1967462829 @default.
• W2791688663 cites W1988558796 @default.
• W2791688663 cites W2013787330 @default.
• W2791688663 cites W2021622568 @default.
• W2791688663 cites W2023040927 @default.
• W2791688663 cites W2040379747 @default.
• W2791688663 cites W2041694981 @default.
• W2791688663 cites W2059296313 @default.
• W2791688663 cites W2073934456 @default.
• W2791688663 cites W2078891912 @default.
• W2791688663 cites W2093562222 @default.
• W2791688663 cites W2104298688 @default.
• W2791688663 cites W2107415042 @default.
• W2791688663 cites W2114418380 @default.
• W2791688663 cites W2124403004 @default.
• W2791688663 cites W2127780961 @default.
• W2791688663 cites W2133914697 @default.
• W2791688663 cites W2134580330 @default.
• W2791688663 cites W2153952034 @default.
• W2791688663 cites W2159416556 @default.
• W2791688663 cites W3153143002 @default.
• W2791688663 doi "https://doi.org/10.1158/1940-6207.capr-17-0293" @default.
• W2791688663 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29437696" @default.
• W2791688663 hasPublicationYear "2018" @default.
• W2791688663 type Work @default.
• W2791688663 sameAs 2791688663 @default.
• W2791688663 citedByCount "24" @default.
• W2791688663 countsByYear W27916886632018 @default.
• W2791688663 countsByYear W27916886632019 @default.
• W2791688663 countsByYear W27916886632020 @default.
• W2791688663 countsByYear W27916886632021 @default.
• W2791688663 countsByYear W27916886632022 @default.
• W2791688663 countsByYear W27916886632023 @default.
• W2791688663 crossrefType "journal-article" @default.
• W2791688663 hasAuthorship W2791688663A5004506157 @default.
• W2791688663 hasAuthorship W2791688663A5009110617 @default.
• W2791688663 hasAuthorship W2791688663A5019534637 @default.
• W2791688663 hasAuthorship W2791688663A5031936639 @default.
• W2791688663 hasAuthorship W2791688663A5033444828 @default.
• W2791688663 hasAuthorship W2791688663A5048359390 @default.
• W2791688663 hasAuthorship W2791688663A5054090794 @default.
• W2791688663 hasAuthorship W2791688663A5054472987 @default.
• W2791688663 hasAuthorship W2791688663A5060618328 @default.
• W2791688663 hasAuthorship W2791688663A5075288631 @default.
• W2791688663 hasAuthorship W2791688663A5091770473 @default.
• W2791688663 hasBestOaLocation W27916886632 @default.
• W2791688663 hasConcept C121608353 @default.
• W2791688663 hasConcept C126322002 @default.
• W2791688663 hasConcept C131872663 @default.
• W2791688663 hasConcept C141071460 @default.
• W2791688663 hasConcept C142724271 @default.
• W2791688663 hasConcept C167135981 @default.
• W2791688663 hasConcept C18823058 @default.
• W2791688663 hasConcept C2776117191 @default.
• W2791688663 hasConcept C2777343196 @default.
• W2791688663 hasConcept C2778220009 @default.
• W2791688663 hasConcept C29456083 @default.
• W2791688663 hasConcept C71924100 @default.
• W2791688663 hasConcept C72563966 @default.
• W2791688663 hasConceptScore W2791688663C121608353 @default.
• W2791688663 hasConceptScore W2791688663C126322002 @default.
• W2791688663 hasConceptScore W2791688663C131872663 @default.
• W2791688663 hasConceptScore W2791688663C141071460 @default.
• W2791688663 hasConceptScore W2791688663C142724271 @default.
• W2791688663 hasConceptScore W2791688663C167135981 @default.
• W2791688663 hasConceptScore W2791688663C18823058 @default.
• W2791688663 hasConceptScore W2791688663C2776117191 @default.
• W2791688663 hasConceptScore W2791688663C2777343196 @default.
• W2791688663 hasConceptScore W2791688663C2778220009 @default.
• W2791688663 hasConceptScore W2791688663C29456083 @default.
• W2791688663 hasConceptScore W2791688663C71924100 @default.
• W2791688663 hasConceptScore W2791688663C72563966 @default.
• W2791688663 hasIssue "3" @default.
• W2791688663 hasLocation W27916886631 @default.
• W2791688663 hasLocation W27916886632 @default.
• W2791688663 hasLocation W27916886633 @default.
• W2791688663 hasOpenAccess W2791688663 @default.
• W2791688663 hasPrimaryLocation W27916886631 @default.
• W2791688663 hasRelatedWork W2033795923 @default.
• W2791688663 hasRelatedWork W2042683710 @default.
• W2791688663 hasRelatedWork W2065397239 @default.
• W2791688663 hasRelatedWork W2083732545 @default.

• next